The Role of Troponin And Il-6 in Immunological Assessment of Sarcopenia in Oncological Patients

Sarcopenia is a progressive syndrome associated with aging, leading to decreased muscle mass and function. This study aims to evaluate troponin and IL-6 as immunological biomarkers in sarcopenia. Methods: 180 patients aged 65–86 were analyzed for serum troponin T and IL-6 levels. Statistical analyses included Mann–Whitney U and logistic regression. Troponin was significantly elevated in sarcopenic patients. IL-6 showed a non-significant upward trend. Troponin was identified as an independent predictor. Troponin and IL-6 may serve as useful clinical biomarkers for sarcopenia. Troponin, in particular, holds promise for early detection.